Fisheries and Aquatic Sciences

한국수산과학회 (The Korean Society of Fisheries and Aquatic Science)
권호 표지
DOI QR코드

DOI QR Code

Application of tylosin antibiotics to olive flounder (Paralichthys olivaceus) infected with Streptococcus parauberis

  • Joo, Min-Soo (Institute of Marine Industry, College of Marine Science, Gyeongsang National University) ;
  • Hwang, Seong Don (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Choi, Kwang-Min (Institute of Marine Industry, College of Marine Science, Gyeongsang National University) ;
  • Kim, Yoon-Jae (Department of Fisheries Science, Aquatic Life Medicine, Pukyong National University) ;
  • Hwang, Jee Youn (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Kwon, Mun-Gyeong (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Jeong, Ji-Min (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Seo, Jung Soo (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Lee, Ji Hoon (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Lee, Hee-Chung (Aquatic Animal Disease Control Center, National Institute of Fisheries Science (NIFS)) ;
  • Park, Chan-Il (Institute of Marine Industry, College of Marine Science, Gyeongsang National University)
  • 투고 : 2020.04.06
  • 심사 : 2020.07.13
  • 발행 : 2020.08.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Olive flounder, Paralichthys olivaceus, is an economically important aquaculture species in Korea. Olive flounders have been heavily damaged by streptococcal infections every year and are treated with antibiotics. However, antibiotic abuse is causing the emergence of resistant strains, and to overcome this, research has shown that new antibiotics must be applied. Tylosin is a relatively safe antibiotic and has good activity against Gram-positive bacteria and mycoplasma. We studied the therapeutic effects and side effects of tylosin on Streptococcus parauberis-infected olive flounder. Methods: After artificial infection of olive flounder with S. parauberis SPOF18J3, an appropriate dose of tylosin was confirmed by intramuscular injection (I.M.) at 2.5, 5, 10, and 15 mg/kg, and oral administration at 10 and 20 mg/kg. After I.M. and oral administration dosing of tylosin, side effects were confirmed by serological analysis, histopathological analysis, and median lethal dose (LD50) analysis at both an appropriate concentration and a high concentration. Statistical analysis was performed using one-way analysis of variance (ANOVA) and Tukey's test (p < 0.05). Results: The appropriate I.M. and oral administration concentration of tylosin administered to olive flounder infected with S. parauberis SPOF18J3 was found to be 10 mg/kg. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were showed not significantly different between the control group and the experimental groups. The histopathologic results showed mild inflammatory responses in muscle and tubular vacuolization and tubular atrophy appeared, but there were no significant differences between the groups. The LD50 was confirmed to be 461 mg/kg. Conclusion: In this study, an effective treatment method was provided by verifying the treatment effects and side effects of tylosin in olive flounder infected with S. parauberis, which can be applied directly to aquaculture sites. In addition, these results may be used as a reference for evaluation required upon request to obtain approval for tylosin antibiotics as fishery antibiotics in Korea. After approval, it is possible that a fishery disease manager will be able to prescribe and sell the antibiotic tylosin.

키워드

참고문헌

  1. Anderson RC, Harris PN, Lee CC, Maze N, Small RM, Worth HM. The toxicology and pharmacology of tylosin, an antibiotic, and some salts of tylosin. Unpublished report No. VAR.100/c/9 from Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA. 1966.
  2. Anderson RC, Worth HM. The acute toxicity of tylosin phosphate. Unpublished study No. 893/TACUTE/AM from Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA. 1961.
  3. Augusto J, Smith B, Smith S, Robertson J, Reimschuessel R. Gentamicin-induced nephrotoxicity and nephroneogenesis in Oreochromis nilotica, a tilapian fish. Dis. Aquat. Org. 1996;26(1):49-58. https://doi.org/10.3354/dao026049
  4. Baggot JD. Some aspects of clinical pharmacokinetics in veterinary medicine: principles of pharmacokinetics. J. Vet. Pharmacol. Ther. 1978;1:111-8. https://doi.org/10.1111/j.1365-2885.1978.tb00314.x
  5. Corcoran JW, Huber ML, Huber FM. Relationship of ribosomal binding and antibacterial properties of tylosin-type antibiotics. J. Antibiot. 1977;30(11):1012-4. https://doi.org/10.7164/antibiotics.30.1012
  6. Finney DJ. Probit analysis. 3rd ed. Cambridge: Cambridge University Press; 1971.
  7. Gingerich DA, Baggot JD, Kowalski JJ. Tylosin antimicrobial activity and pharmacokinetics in cows. Can. Vet. J. 1997;18(4):96-100.
  8. Huang XJ, Choi YK, Im HS, Yarimaga O, Yoon E, Kim HS. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors. 2006;6(7):756-82. https://doi.org/10.3390/s6070756
  9. Jee BY, Shin KW, Lee DW, Kim YJ, Lee MK. Monitoring of the mortalities and medications in the inland farms of olive flounder, Paralichthys olivaceus, in South Korea. J. Fish Pathol. 2014;27(1):77-83. https://doi.org/10.7847/jfp.2014.27.1.077
  10. Joint FAO/WHO Expert Committee on Food Additives (JECFA). Toxicological evaluation of certain veterinary drug residues in food: Tylosin. 2009.
  11. Katz SE, Bardy MS. Antibiotic residues in food and their significance. Food Biotechnol. 2000;14(3):147-71. https://doi.org/10.1080/08905430009549985
  12. Kim JW, Cho MY, Jee BY, Park MA, Kim NY. Administration and use of aquaculture drugs in Korea. J. Fish Pathol. 2014;17(1):67-75.
  13. Kim JW, Lee HN, Jee BY, Woo SH, Kim YJ, Lee MK. Monitoring of the mortalities in the aquaculture farms of South Korea. J. Fish Pathol. 2012;25(3):271-7. https://doi.org/10.7847/jfp.2012.25.3.271
  14. Kowalski C, Rolinski Z, Zan R, Wawron W. Pharmacokinetics of tylosin in broiler chickens. Pol. J. Vet. Sci. 2002;5:127-30.
  15. Lewicki J. Tylosin. A review of pharmacokinetics, residues in food animals and analytic methods. Available at the website of FAO at: ftp://ftp.fao.org/ag/agn/food/tylosin_2006.pdf (Accessed 10 August 2008). 2006.
  16. Marsteller T, Winkelman N, Gebhart C, Armbruster G, Weldon W, Muller PR, Weatherford PJ, Symanowski J. Efficacy of intramuscular tylosin for the treatment and control of porcine proliferative enteropathy caused by Lawsonia intracellularis. Vet. Ther. 2001;3(1):5-7.
  17. Mata AI, Gibello A, Casamayor A, Blanco MM, Dominguez L, FernandezGarayzabal JF. Multiplex PCR assay for detection of bacterial pathogens associated with warm-water Streptococcosis in fish. Appl. Environ. Microbiol. 2004;70:3183-7. https://doi.org/10.1128/AEM.70.5.3183-3187.2004
  18. Mishra A, Nam GH, Gim JA, Lee HE, Jo A, Kim HS. Current challenges of Streptococcus infection and effective molecular, cellular, and environmental control methods in aquaculture. Mol. Cells. 2018;41:495-505.
  19. Morton DM. Tylan products. Expert report on toxicological documentation. Unpublished report from Lilly research Laboratories, Eli Lilly and Company, Greenfield, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA, 1988.
  20. NIFS. Investigation of safety and efficacy of fishery antibiotics customized by fish species. 2019. Final report.
  21. Prats C, El Korchi G, Francech R, Arboix M, Perez B. Disposition kinetics of tylosin administered intravenously and intramuscularly to pigs. Res. Vet. Sci. 2002;73:141-4. https://doi.org/10.1016/S0034-5288(02)00036-X
  22. Prescott JF, Baggot JD. Antimicrobial therapy in veterinary medicine. 3rd edn. Iowa State University Press, Ames, IA, USA. 1988.
  23. Quarles JP. Acute comparative intravenous toxicity testing of tylosin, desmycosin and macrocin in the ICR mouse. Unpublished studies Nos M-V-46-83, M-V45-83 and M-V-44-83 from the Toxicology Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA. Submitted to WHO by Elanco Animal Health, Division of Eli Lilly and Company, Indianapolis, IN, USA. 1983.
  24. Reimschuessel R, Chamie SJ, Kinnel M. Evaluation of gentamicin-induced nephrotoxicosis in toadfish. J. Am. Vet. Med. Assoc. 1996;209(1):137-9.
  25. Reimschuessel R, Williams D. Development of new nephrons in adult kidneys following gentamicin-induced nephrotoxicity. Ren. Fail. 1995;17(2):101-96. https://doi.org/10.3109/08860229509026246
  26. Shim JD, Hwang SD, Jang SY, Kim TW, Jeong JM. Monitoring of the mortalities in oliver flounder (Paralichthys olivaceus) farms of Korea. J. Fish Pathol. 2019;32(1):029-35. https://doi.org/10.7847/JFP.2019.32.1.029
  27. Smith P, Hiney MP, Samuelsen OB. Bacterial resistance to antimicrobial agents used in fish farming: a critical evaluation of method and meaning. Annu. Rev. Fish Dis. 1994;4:273-313. https://doi.org/10.1016/0959-8030(94)90032-9
  28. Solez K. The pathology and pathogenesis of human "acute tubular necrosis", In Solez, K. and Whelton, A. Acute renal failure: correlations between morphology and function. Marcel Dekker, Inc., New York. 1984; pp.17-42.
  29. Widmer AF. New development in diagnosis and treatment of infection in orthopaedic implants. Clin. Infect. Dis. 2001;33:S94-106. https://doi.org/10.1086/321863
  30. Ziv G, Sulman FG. Serum and milk concentrations of spectinomycin and tylosin in cows and ewes. Am. J. Vet. Res. 1973;34:329-33.

피인용 문헌

  1. Pharmacokinetic-Pharmacodynamic Profile, Bioavailability, and Withdrawal Time of Tylosin Tartrate Following a Single Intramuscular Administration in Olive Flounder (Paralichthys olivaceus) vol.11, pp.8, 2020, https://doi.org/10.3390/ani11082468